Related Experiment Videos
Lower gastrointestinal bleeding in inflammatory bowel disease
1Division of Medicine, Cleveland Clinic Foundation, Ohio 44195-5014.
Insights
Inflammatory bowel disease (IBD) is a chronic condition requiring long-term management. This study highlights IBD
Area of Science:
- Gastroenterology
- Internal Medicine
- Chronic Disease Management
Background:
- Increasing incidence of inflammatory bowel disease (IBD) observed over recent decades.
- IBD presents as chronic conditions necessitating long-term medication, surgery, and management of complications.
- Early onset of IBD in young patients increases the risk of recurrences and complications, underscoring clinical significance.
Purpose of the Study:
- To determine the long-term prognosis of inflammatory bowel disease (IBD) based on extensive patient follow-up.
- To analyze the clinical course, complications, and treatment outcomes in patients with ulcerative colitis and Crohn's disease.
Main Methods:
- Retrospective analysis of a large cohort of inflammatory bowel disease (IBD) patients at Cleveland Clinic.
- Long-term follow-up to assess disease progression, surgical interventions, and recurrence rates.
- Evaluation of specific symptoms like rectal bleeding and their implications for treatment decisions.
Main Results:
- Inflammatory bowel disease (IBD) is characterized by chronicity, frequent need for surgery (especially Crohn's disease), and recurrences.
- Rectal bleeding is common in ulcerative colitis and occurs in a subset of Crohn's disease patients; severe hemorrhage is rare (1-5%).
- Long-term challenges in Crohn's disease include high rates of surgery (2/3-3/4) and recurrence (approx. 50%).
Conclusions:
- Inflammatory bowel disease (IBD) requires ongoing management due to its chronic nature and potential for complications.
- Surgical intervention and recurrence are significant long-term concerns, particularly for Crohn's disease patients.
- Understanding long-term prognosis is crucial for effective patient care and management strategies in IBD.
Abstract:
An increasing number of patients with inflammatory bowel disease (IBD) have been observed over the past two to three decades at the Cleveland Clinic. This has allowed extensive follow-up and determination of long-term prognosis. The diseases are chronic, require medication over a long period of time, are frequently associated with the need for operation, and often have complications and recurrences. In addition, a substantial number of patients have onset disease at a young age and thus, the propensity for recurrences and complications makes IBD of significant clinical importance. The symptoms of IBD are chronic and usually include diarrhea and often malnutrition. Rectal bleeding is found in almost all patients with ulcerative colitis and in about 25% of patients with Crohn's disease. However, severe hemorrhage in IBD occurs in a small number (1-5%) of patients. When this occurs, it often does so as an episode which may be associated with severe illness systemically as well as creating diagnostic confusion. For patients with ulcerative colitis, the progressive severity of bleeding may be an important indication for surgery (colectomy); in Crohn's disease, patients with ileocolic location of disease are more likely to have severe hemorrhage, and may require resection as a result. Despite the similarities of Crohn's disease and ulcerative colitis, there are significant differences particularly in the long-term (greater than 10 years) follow-up. For patients with Crohn's disease, the major long-term problem is the need for surgery (2/3-3/4 of patients) and recurrence (+/- 50%).(ABSTRACT TRUNCATED AT 250 WORDS)